维普中文期刊产品整合服务
109篇 您的检索式:作者名="N Miyanaga"
    题名 作者 年代 出处 被引量
1A significant association of viral loads with corneal endothelial cell damage in cytomegalovirus anterior uveitis显示文摘Miyanaga M Sugita S Shimizu N 0,,03:1
2查看详情显示文摘Miyaji G Miyanaga N Umshihara S Suzuki K Matsuoka S Nakatsuka M 0,,:1
3A bladder preservation regimen using intra-arterial chemotherapy and radiotherapy for invasive bladder cancer: a prospective study显示文摘Miyanaga N Akaza H Okumura T 2000Int J Urol2000,7,2:1
4Comparisons of percent equol producers between prostate cancer patients and controls:case-controlled studies of isoflavones in Japanese,Korean and American residents显示文摘Akaza H Miyanaga N Takashima N 2004Jpn J Clin Oncol2004,34,2:1
5Background Variables for the Patients with Invasive Bladder Cancer Suitable for Bladder-preserving Therapy显示文摘MIYANAGA N AKAZA H HINOTSU S 2007Jpn J Clin Oncol2007,37,11:1
6Clinical evaluation of nuclear matrix protein 22( NMP2: ) in urine as a novel marker for urothelial cancer显示文摘Miyanaga N Akaza H Ishikawas V 1997Eur Urol1997,31,:1
7Evaluationof urinary NMP22(nuclear matrix protein 22)as a diag-nostic marker for urothelial cancer-NMP22 as a urinarymarker for surveillance of bladder cancer显示文摘Akaza H Miyanaga N Tsukamoto T 1997J pn JCane Chemother1997,24,:1
8Evaluation of urinary NMP22 as a diagnostic marker for urothelial cancer NMP22 as a urinary marker for surveillance of bladder cancer显示文摘Akaza H Miyanaga N Tsukamoto F 1997Gan To Kagaku Ryoho1997,24,7:1
9Tissue elasticity ima- ging for diagnosis of prostate eaneer:a preliminary report显示文摘Miyanaga N Akaza H Yamakawa M 2006Int J Uro12006,13,12:1
10Clinical evaluation of nuclear matrix protein 22 (NMP22) in urine as a novel marker for urothelial cancer显示文摘Miyanaga N Akaza H Ishikawa S 1997Eur Urol1997,31,:1
11Comparisons of percent equol producers between prostate cancer patients and controls:case-controlled studies of isoflavones in Japanese,Korean and American residents显示文摘AKAZA H MIYANAGA N TAKASHIMA N 2004Jpn J Clin Oncol2004,34,2:1
12Development of 10-kJ PW laser for the FIREX-I program显示文摘Miyanaga N Azechi H Jitsuno T 2006PZasma Physics and Controlled Fusion2006,,:1
13Evaluation of urinary NMP22 (unclear matrix protein 22) as a diagnostic marker for urothelial cancer screening for urothelial cancer in patients with microscopic hematuria显示文摘Akaza H Miyanaga N Tsukamoto T 1997Gan To Kagaku Ryoho1997,24,7:1
14Evaluation of urinary NMP22(nuclear matrix protein 22) as a diagnostic marker for urothelial cancer NMP22 as a urinary marker for surveillance of bladder cancer 显示文摘Akaza H Miyanaga N Tsukamoto T 1997Gan To Kagaku Ryoho1997,24,7:1
15Antineoplastic activity of honey in an experimental bladder cancer implantation model: in vi- vo and in vitro studies显示文摘Swellam T Miyanaga N Onozawa M 2003Imernational Journal of Urology2003,10,4:1
16Neutron penumbral imaging at Gekko ⅩⅡ显示文摘Miyanaga N Chen Y W Yamanaka M 1990Rev Sci Instrum1990,61,10:1
17Analysis of intravesical recurrence after bladder-preserving ther- apy for muscie-invasive bladder cancer显示文摘OnozawaM Miyanaga N Hinotsu S 2012Jpn J Clin Oncol2012,42,9:1
18Tissue elasticity imag-ing for diagnosis of prostate cancer: a preliminary report 显示文摘Miyanaga N Akaza H Yamakawa M 2006Int JUrol2006,13,12:1
19A significant association of viral loads with corneal endothelial cell damage in cytomegalovirus anterior uveitis显示文摘Miyanaga M Sugita S Shimizu N 2010BrJ Ophthalmol2010,94,:1
20Random Phasing of high-power lasers for uniform target acceleration and plasma instability suppression显示文摘KATO Y MIM K MIYANAGA N 1984Phys Revi Letts1984,53,11:1
返回顶部 每页显示:
共6页 首页 上一页 第1页 下一页 末页 /6 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费